Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Safety, Acceptance, and Hesitancy of Covid-19 Vaccines Among High-Risk Sub-Populations: A Narrative Review Publisher



Alinia T1 ; Shojaei S2 ; Rahimi Pordanjani S3 ; Barati H2 ; Hovsepian S1 ; Hashemi Nazari SS2, 4 ; Panahi MH2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Metabolic Liver Disease Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Social Determinants of Health Research Center, Department of Epidemiology and Biostatistics, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
  4. 4. Prevention of Cardiovascular Disease Research Center, Safety Promotion and Injury Prevention Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Journal of Pediatrics Review Published:2023


Abstract

To end the new COVID-19 pandemic, most of the world’s population needs to be immune to the virus, protecting individuals from infection, and ultimately ensuring herd immunity at the population level. A variety of COVID-19 vaccines have been developed worldwide for adults and children over the age of 12 years, and the effectiveness of the vaccine in preventing symptomatic diseases and hospitalization is being studied. One of the major obstacles to COVID-19 vaccination that has emerged along with the global immunization program is vaccine hesitation or disapproval. The World Health Organization (WHO) has reported vaccine hesitation as one of the 10 global health threats of 2019. This is also related to COVID-19. The present review, explore the current evidence on COVID-19 vaccination platforms and vaccination efficacy, safety, and adverse effects among strategic sub-populations, including elderly people, people with chronic disease (diabetes, cancer), pregnant and lactating women, children, youth, and vaccination willingness or hesitancy among the target population. © 2023, Negah Institute for Scientific Communication. All rights reserved.
Related Docs
View other Related Docs
1. A Comprehensive Review on Various Aspects of Sars-Cov-2 (Covid-19) Vaccines, International Journal of Preventive Medicine (2022)
2. Association of Prior Covid‑19 Infection With Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran, International Journal of Preventive Medicine (2024)
3. Comparative Study of the Level of Neutralizing Antibodies in People Injecting 4 Types of Covid-19 Vaccine; [بررسیمقایسهایسطح آنتیبادیخنثیکنندهدر افراد تزریقکنندهی4نوع واکسن کووید-], Journal of Isfahan Medical School (2024)
4. Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of Covid.19 Pandemic: A Narrative Review, International Journal of Preventive Medicine (2021)
5. Covid-19 Vaccine Boosters: The Good, the Bad, and the Ugly, Vaccines (2021)
6. Topics and Users' Emotions on Social Media Regarding the Covid-19 Vaccine: A Systematic Review, Ethiopian Medical Journal (2023)
7. Covid-19 Vaccination in Patients With Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to Covid-19: A Usidnet Report, Journal of Clinical Immunology (2024)
8. Different Approaches to Confronting the Biological Epidemic; Prevention Tools With an Emphasis on Covid-19: A Systematized Study, International Journal of Preventive Medicine (2021)
Experts (# of related papers)
View all Related Experts
Shaghayegh Haghjooy Javanmard (8)
Roya Kelishadi (6)
Other Related Docs
9. Efficacy and Side Effects of Sputnik V, Sinopharm and Astrazeneca Vaccines to Stop Covid-19; a Review and Discussion, Immunopathologia Persa (2021)
10. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
11. Covid-19 Vaccines: Current and Future Challenges, Frontiers in Pharmacology (2024)
12. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
13. Importance of the Covid-19 Vaccine Booster Dose in Protection and Immunity, Vaccines (2022)
14. Covid-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran, Vaccines (2022)
15. Convalescent Plasma Therapy for Covid-19: Lessons From Sars-Cov, Mers-Cov, and H1n1 Infection, Acta Medica Indonesiana (2021)
16. Multiple Sclerosis (Ms) and Neuromyelitis Optica Spectrum Disorder (Nmosd) Following Covid-19 Vaccines: A Systematic Review, Revue Neurologique (2023)
17. High Risk Individuals in Covid-19 Pandemic; an Updated Review, Immunopathologia Persa (2021)
18. Sars-Cov-2 Seroprevalence Among Health-Care Workers in Isfahan, Iran, Advanced Biomedical Research (2023)
19. Presumed Partial Third Nerve Palsy After Covid-19 Vaccination: A Case Report; [احتمال فلج ناقص عصب سوم پس از واکسیناسیون کووید- :19گزارش یک مورد], Journal of Isfahan Medical School (2024)
20. Delivering Primary Health Care (Phc) Services for Controlling Ncds During the Covid-19 Pandemic: A Scoping Review, Journal of Prevention (2023)
21. Vaccine-Associated Complications: A Comparative Multicenter Evaluation Among Dental Practitioners and Dental Students—Which Candidate Vaccine Is More Safe in Sars Cov Ii, Gam-Covid-Vac (Sputnik V), Chadox1 Ncov-19 (Astrazeneca), Bbv152 (Covaxin), or Bbibp-Corv(Sinopharm)?, Maxillofacial Plastic and Reconstructive Surgery (2022)
22. Emerging Coronaviruses: First Sars, Second Mers and Third Sars-Cov-2. Epidemiological Updates of Covid-19, Infezioni in Medicina (2020)
23. Current Status of Covid-19 Pandemic; Characteristics, Diagnosis, Prevention, and Treatment, Journal of Research in Medical Sciences (2020)
24. Covid-19 Breakthrough Infections Among Patients With Cancer Receiving Sinopharm Bibp Vaccine, International Journal of Cancer Management (2022)
25. Does Covid-19 Escalate Aging Process? a Possible Concern, Advanced Biomedical Research (2022)
26. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
27. Seroprevalence of Hepatitis a in Iranian Adolescents: Is It Time to Introduce a Vaccine?, Epidemiology and Infection (2016)
28. Cancer Patients’ Challenges During Covid-19 Pandemic: An Approach to Decision-Making in Management and Policy-Making, Archives of Clinical Infectious Diseases (2021)
29. The Outcomes of Covid-19 Epidemic Crisis on the Elderly: A Review Study, Journal of Isfahan Medical School (2021)
30. Covid19 Prevention & Care; a Cancer Specific Guideline, Archives of Iranian Medicine (2020)
31. Radiation Therapy for Breast Cancer During the Covid-19 Pandemic in Low Resource Countries: Consensus Statement From the Iranian Society of Radiation Oncology, International Journal of Cancer Management (2022)
32. Factors Related to Preventive Covid-19 Behaviors Using Health Belief Model Among General Population: A Cross-Sectional Study in Iran, BMC Public Health (2021)
33. Multiple Sclerosis Relapse After Covid-19 Vaccination: A Case Report-Based Systematic Review, Journal of Clinical Neuroscience (2022)
34. Predictors of Catching Covid-19 Infection During Pandemic Stage in Patients With Multiple Sclerosis (Ms), International Journal of Preventive Medicine (2022)
35. Lactate Dehydrogenase to Albumin Ratio As a Predictive Factor of Covid-19 Patients’ Outcome; a Cross-Sectional Study, Archives of Academic Emergency Medicine (2022)
36. Exacerbation of an Undiagnosed Pre-Existing Lupus Nephritis Following an Inactivated Covid-19 Vaccination, Journal of Nephropharmacology (2022)
37. Cardiovascular Complications of Covid-19 Vaccines: A Review of Case-Report and Case-Series Studies, Heart and Lung (2023)
38. The Covid-19 Pandemic: A Systematic Review of the Current Evidence; [Пандемия Covid-19: Систематический Обзор Современных Данных], Russian Journal of Infection and Immunity (2020)
39. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
40. Monitoring and Active Surveillance of Adverse Events Following the Booster Dose of Azd1222 Vaccine in People Vaccinated With Sinopharm Bbibp-Corv: A Cohort Study, BMC Public Health (2025)
41. The Effect of Covid-19 Vaccination on Reducing the Risk of Infection, Hospitalization, and Death in Isfahan Province, Iran, Iranian Journal of Public Health (2022)
42. The Association Between Adherence to Unhealthy Plant-Based Diet and Risk of Covid-19: A Cross-Sectional Study, BMC Infectious Diseases (2024)
43. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
44. Cardiovascular Complications of Sars-Cov-2 Vaccines: An Overview, Cardiology and Therapy (2022)
45. Sars-Cov-2 Serology Among People With Multiple Sclerosis on Disease-Modifying Therapies After Bbibp-Corv (Sinopharm) Inactivated Virus Vaccination: Same Story, Different Vaccine, Multiple Sclerosis and Related Disorders (2022)
46. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
47. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
48. Covid-19 Infection Risk Following Elective Arthroplasty and Surgical Complications in Covid-19-Vaccinated Patients: A Multicenter Comparative Cohort Study, Arthroplasty Today (2022)
49. Survival Analysis for Predictive Factors of Delay Vaccination in Iranian Children, International Journal of Preventive Medicine (2015)
50. Efficacy of Hydroxychloroquine in Pre-Exposure Severe Acute Respiratory Syndrome Coronavirus 2 Prophylaxis Among High-Risk Healthcare Workers: A Multicenter Study, Advanced Biomedical Research (2023)